In this review the authors consider the new science of Darwinian medicine.

• Abstract
• Background: evolutionary medicine
• Evolution: Darwin and beyond
• The biomedical sciences: variation and species differences
• Host-parasite co-evolution
• The immune system and cancer
• Conclusion
• References

Biology Articles » Evolutionary Biology » Evolution and medicine: the long reach of "Dr. Darwin" » References

References

- Evolution and medicine: the long reach of "Dr. Darwin"

1.   Burggren WW, Bemis WE: Studying physiological evolution: paradigms and pitfalls.In Evolutionary Innovations. Edited by: Nitecki MH. Chicago: University of Chicago Press; 1990:191-228.       2.   Ewald PW: The Evolution of Infectious Disease. Oxford: Oxford University Press; 1994.       3.   Darwin C: The Origin of Species. Edited by: Appleman P. New York: WW Norton; 1972.       4.   Sober E: Philosophy of Biology. Boulder, CO: Westview; 2000.       5.   Gerhart J, Kirschner M: Cells, Embryos and Evolution: Toward a Cellular and Developmental Understanding of Phenotypic Variation and Evolutionary Adaptability. Oxford: Blackwell; 1997.       6.   Kirschner MW, Gerhart JC: The Plausibility of Life: Resolving Darwin's Dilemma. New Haven: Yale University Press; 2005.       7.   Davidson E: Genomic Regulatory Systems: Development and Evolution. St. Louis: Academic Press (Elsevier); 2001.       8.   Davidson E: The Regulatory Genome: Gene Regulatory Networks in Development and Evolution. St. Louis: Academic Press (Elsevier); 2006.       9.   Carroll SB, Grenier JK, Weatherbee SD: From DNA to Diversity: Molecular Genetics and the Evolution of Life's Diversity. Oxford, Blackwell; 2001.       10.   Carroll SB: Endless Forms most Beautiful: The New Science of Evolution and the Making of the Animal Kingdom. New York: W.W. Norton; 2005.       11.   Ewald PW: Plague Time: The New Germ Theory of Disease. New York: Anchor Press; 2002.       12.   Nesse RM, Williams GC: Why We Get Sick: The New Science of Darwinian Medicine. New York: Vintage Books; 1995.         13.   Parham P: The rise and fall of great class I genes.Seminars in Immunology 1994, 6(6):373-382.       14.   Frank SA: Immunology and the Evolution of Infectious Disease. Princeton: Princeton University Press; 2002.       15.   Greaves M: Cancer: The Evolutionary Legacy. Oxford: Oxford University Press; 2000.       16.   Shanks N: Animals and Science: A Guide to the Debates. Santa Barbara: ABC-Clio; 2002.       17.   Boguski MS: Comparative genomics: the mouse that roared.Nature 2002, 420:515-516.       18.   Guengerich FP: Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species.Chemico-Biological Interactions 1997, 106:161-182.       19.   Marshall E: First check my genome, doctor.Science 2003, 302:589.       20.   Sipes IG, Gandolfi AJ: Biotransformation of Toxicants.In Casarett and Doull's Toxicology. Edited by: Amdour A, Doull J, Klaassen C. New York: McGraw-Hill; 1993:2-49.       21.   Weinshilboum R: Inheritance and drug response.The New England Journal of Medicine 2003, 348:529-537.       22.   Tateishi T, Chida M, Ariyoshi N, Mizorogi Y, Kamatake T, Kobayashi S: Analysis of the CYP2D6 gene in relation to dextromorphen O-demethylation capacity in a Japanese population.Clinical Pharmacology and Therpeutics 1999, 65:570-575.       23.   Collins JM: Inter-species differences in drug properties.Chemico-Biological Interactions 2001, 134:237-242.       24.   Hoffman GR: Genetic Toxicology.In Casarett and Doull's Toxicology. Edited by: Amdour A, Doull J, Klaassen C. New York: McGraw-Hill; 1993:12-49.       25.   Alberts BR, Johnson A, Lewis J, Raff M, Roberts K, Walter P: The Molecular Biology of the Cell. New York: Garland; 2002.       26.   Salsburg D: The lifetime feeding study in mice and rats – an examination of its validity as a bioassay for human carcinogenesis.Fundamental and Applied Toxicology 1983, 3:63-67.       27.   Lave LB, Ennever FK, Rosencrantz HS, Ommen GS: Information value of the rodent bioassay.Nature 1988, 336:631-633.       28.   Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddell C, Blanchard SG, Willson TM, Collins JL, Kliewer SA: Orphan nuclear receptors constitutive androstane receptor and pregnane x receptor share xenobiotic and steroid ligands.The Journal of Biological Chemistry 2000, 275:15122-15126.       29.   Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NCO, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore JT: The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.Molecular Endocrinology 2000, 14:27-39.       30.   Greek CR, Greek JS: Specious Science: How Genetics and Evolution Reveal Why Medical Research on Animals Harms Humans. New York: Continuum; 2002.       31.   Willson TM, Kliewer SA: PXR, CAR and drug metabolism.Nature Reviews Drug Discovery 2002, 1:259-266.       32.   Goldstein DB: Pharmacogenetics in the Laboratory and the Clinic.The New England Journal of Medicine 2003, 348:553-556       33.   Hart J: Endocrine pathology of estrogens: species differences.Pharmacological Therapy 1990, 47:203-218.       34.   Spearow JL, Barkley M: Assessment of models used to test xenobiotics for oestrogenic potency is overdue.Human Reproduction 2001, 16:1027-1029.       35.   Evans WE, McLeod HL: Pharmacogenomics – drug disposition, drug targets, and side effects.New England Journal of Medicine 2003, 348:538-549.       36.   Goldstein DB, Hirschorn JN: In genetic control of disease, does "race" matter?Nature Genetics 2004, 36(12):1243-1244.       37.   Holden C: Race and medicine.Science 2003, 302:594-596.       38.   Couzin J: In asians and whites, gene expression varies by race.Science 2007, 315:173-174.       39.   Mayr E: What Makes Biology Unique? Considerations on the Autonomy of a Scientific Discipline. Cambridge: Cambridge University Press; 2004.